Clinical Trial

An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated April 3, 2025 (before its estimated July 2025 completion). Its status may not reflect the trial's current state.
Summary
An Open Label Clinical Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adult Patients With Focal Onset or Primary Generalized Tonic-Clonic Seizures
Trial Details
NCT Number NCT06908356
Lead Sponsor Praxis Precision Medicines
Conditions Focal Onset Seizure, Primary Generalized Epilepsy
Enrollment 50 participants
Start Date 2025-01-10
Primary Completion 2025-07 (estimated)
Study Completion 2025-07 (estimated)
Updated on ClinicalTrials.gov 2025-04-03